NotAnotherEmpire t1_j5y7j91 wrote
Reply to comment by WritingTheRongs in The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC by shiruken
There's no material number of people besides newly old enough children who are getting their first sequence anymore. This is boosted vs. unboosted vaccine.
Viewing a single comment thread. View all comments